drugset / Trial / NCT04470479

Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome

NCT04470479

Phase 3 Completed 32 enrolled Federal University of São Paulo
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study was to access the possible beneficial effects of oral use of pilocarpine in relieving signs and symptoms of patients with Sjogren's syndrome

Timeline

Start
2005-03-01
Primary completion
2006-04-01
Completion
2006-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pilocarpine Unknown 5 mg Oral

Indications